Ordering Options forMyOme Reports and Tests

Learn more about the genetic tests and reports that are coming soon or are in development for the MyOme Personal Genome platform. MyOme Personal Genome unlocks a lifetime of health information from only one sample submission, and our MyOme Genetic Tests cover a range of clinical conditions*.

Coming Soon to the MyOme Platform

MYOME PERSONAL GENOME RISK REPORTS

Coronary Artery Disease (CAD) Integrated Risk with Personal Risk Score (PRS) Report1212

CAD is the most common type of heart disease in the U.S., impacting people of all ages, with 2 in 10 deaths from CAD occurring in adults under 65.1 We’re developing this report so everyone can check their heart health anytime.

About the Report

The report provides a single risk score that integrates genetics with clinical factors to assess risk for coronary artery disease (CAD) for those who may be missed by clinical evaluation (whereas traditional genetic panels evaluate rare genes impacting a small percent and do not assess CAD risk).

Breast Cancer Integrated Risk with Personal Risk Score (PRS) Report

Despite current testing guideline recommendations for NDD, 2 out of 3 children do not receive genetic testing. 5 Current testing is complex and expensive, often leaving families without a clear diagnosis. Our test offers a comprehensive genetic testing option that streamlines the path ahead for families.

About the Report

The report provides a single risk score that integrates genetics with clinical factors to assess risk for coronary artery disease (CAD) for those who may be missed by clinical evaluation (whereas traditional genetic panels evaluate rare genes impacting a small percent and do not assess CAD risk).

MYOME GENETIC TESTS

Neurodevelopmental Delay (NDD) Genetic Test

Despite current testing guideline recommendations for NDD, 2 out of 3 children do not receive genetic testing. 5 Current testing is complex and expensive, often leaving families without a clear diagnosis. Our test offers a comprehensive genetic testing option that streamlines the path ahead for families.

About the Report

The report provides a single risk score that integrates genetics with clinical factors to assess risk for coronary artery disease (CAD) for those who may be missed by clinical evaluation (whereas traditional genetic panels evaluate rare genes impacting a small percent and do not assess CAD risk).

MYOME PERSONAL GENOME RISK REPORTS

  1. National Center for Health Statistics. Multiple Cause of Death 2018–2021 on CDC WONDER Database. Accessed September 13, 2023
  2. Breast Cancer Facts and Statistics 2023, www.breastcancer.org/facts-statistics. Accessed 13 Sept. 2023.
  3. Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol. 2015 Jul;26(7):1291-9. doi: 10.1093/annonc/mdv022. Epub 2015 Jan 20. PMID: 25605744; PMCID: PMC4478970.
  4. Tshiaba, P., et al. Improved Breast Cancer Risk Stratification by Integration of a Cross-ancestry Polygenic Model with Clinical Risk Factors # PB3447 Presented at the Annual Meeting of The American Society of Human Genetics, October 27, 2022, Los Angeles
  5. Savatt Juliann M. et al, Frontiers in Pediatrics V92021* In some cases an additional sample might be required.

Contact Us

We are happy to answer any questions. Contact us at info@myome.com with any questions or to keep apprised of any development, provide your name and email information.

footer logo
linkdin

© 2023 MyOme.com

MyOme is not responsible for the content or accuracy of third-party websites

The MyOme Personal Genome Report was developed, and its performance characteristics were determined, by MyOme, Inc., a clinical laboratory certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high complexity clinical laboratory testing. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary for laboratory-developed tests.